Glipizide
- Product NDC
- 72888-231
- 11-digit product format
- 728880231
- Labeler code
- 72888
- Product ID
- 72888-231_4c5799dd-65b6-d94e-e063-6294a90a066b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Advagen Pharma Limited
- Application
- ANDA214874
- Marketing category
- ANDA
- Marketing start
- 2023-10-03
- Substance
- GLIPIZIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 15 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 310488, 310490, 379804, 2737151 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72888-231-00 | Glipizide | 1000 in 1 BOTTLE | TABLET | 1000 | | 6 |
| 72888-231-01 | Glipizide | 100 in 1 BOTTLE | TABLET | 100 | | 6 |
| 72888-231-05 | Glipizide | 500 in 1 BOTTLE | TABLET | 500 | | 6 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72888-231-00 | 72888023100 | 1000 TABLET in 1 BOTTLE (72888-231-00) | 1000 tablet | 2026-02-04 | No | No | Current |
| 72888-231-01 | 72888023101 | 100 TABLET in 1 BOTTLE (72888-231-01) | 100 tablet | 2026-02-04 | No | No | Current |
| 72888-231-05 | 72888023105 | 500 TABLET in 1 BOTTLE (72888-231-05) | 500 tablet | 2026-02-04 | No | No | Current |